Table II. Evaluation of the ASEB method. While testing a specific known peptide, the other peptides were used as the predefined peptide set. While testing the background peptides that were randomly selected, the known peptides for each family were used as the predefined peptide set.
| Total peptides | CBP/p300 |
GCN5/PCAF |
||
|---|---|---|---|---|
| Known | Background | Known | Background | |
| 267 | 1000 | 82 | 1000 | |
| Significant peptides (p value ≤1e-4) | 36 | 32 | 10 | 11 |
| Significant peptides (p value ≤1e-3) | 64 | 65 | 16 | 22 |
| Significant peptides (p value ≤1e-2) | 101 | 111 | 29 | 47 |
| Significant peptides (p value ≤1e-1) | 149 | 243 | 43 | 144 |